Please login to read the full article.
Scrip Regulatory Affairs
Imminent EU guidance to mandate ICH annual safety report for investigational drugs
08 April 2011
Neena Brizmohun
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- Delay in China's review time for drugs likely to continue; review predictability and transparency improve
- EMA lays out drug safety priorities for 2012
- Feedback sought on EMA reflection paper on clinical testing for tissue-engineered products
- EU pharmacovigilance legislation implementation likely to be staggered
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
